← Browse by Condition
Medical Condition

muscular atrophy spinal

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4, Phase 1

ClinicalMetric tracks all active clinical trials for muscular atrophy spinal sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
1
Phase 4
1
Top Sponsors
Hoffmann-La Roche 1 trial
Biogen 1 trial
NCT05861999 Phase 4
Recruiting

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

Enrollment
28 pts
Location
United States, Germa...
Sponsor
Hoffmann-La Roche
View Trial →
NCT06555419 Phase 1
Recruiting

A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)

Enrollment
58 pts
Location
United States, Franc...
Sponsor
Biogen
View Trial →